Variations [Regulatives / Guidelines]

posted by Helmut Homepage – Vienna, Austria, 2008-08-25 13:06 (6142 d 08:59 ago) – Posting: # 2246
Views: 24,409

Dear D. Labes!

OK, reading all the sections again, I would say they can be shorted into something like: 'The comparative medicinal product in any bioequivalence study (including variations to a generic product) should be the reference medicinal product authorised in the Community, on the basis of a complete dossier [...].'

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,676 registered users;
37 visitors (0 registered, 37 guests [including 8 identified bots]).
Forum time: 22:06 CEST (Europe/Vienna)

Philosophy, like medicine, has plenty of drugs, few good remedies,
and hardly any specific cures.    Sebastien-Roch Nicolas de Chamfort

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5